日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparative Efficacy of Talquetamab vs. Real-World Physician's Choice of Treatment in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma: Updated Analyses of MonumenTAL-1 vs. LocoMMotion/MoMMent

在接受过三类药物治疗的复发/难治性多发性骨髓瘤患者中,Talquetamab 与真实世界医生选择的治疗方案的疗效比较:MonumentTAL-1 与 LocoMMotion/MoMMent 研究的最新分析

Einsele, Hermann; Moreau, Philippe; Bahlis, Nizar; Bhutani, Manisha; Vincent, Laure; Karlin, Lionel; Perrot, Aurore; Goldschmidt, Hartmut; van de Donk, Niels W C J; Ocio, Enrique M; Martínez López, Joaquín; Rodríguez-Otero, Paula; Dytfeld, Dominik; Jakubowiak, Andrzej; Schinke, Carolina; Besemer, Britta; Anguille, Sébastien; Manier, Salomon; Rasche, Leo; Teipel, Raphael; Scheid, Christof; Pawlyn, Charlotte; Cavo, Michele; Diels, Joris; Ghilotti, Francesca; Lau, Bonnie W; Renaud, Thomas; Orel, Oleksiy; Ong, Fenny; Ramos, Diogo F; Ammann, Eric; Parekh, Trilok; Albrecht, Claire; Weisel, Katja; Mateos, María-Victoria

Real-world analysis of multiple myeloma treatments in England using the Cancer Analysis System registry

利用癌症分析系统登记数据对英格兰多发性骨髓瘤治疗进行真实世界分析

Babu, Elma Mary; Fermahan, Sheetal; Bowen, Jonathan; Arnold, Kellyn; Broe, Anne; Lay-Flurrie, Sarah; Matsakidis, Panteleimon; Chetty, Mersha; Pawlyn, Charlotte

Evaluating the impact of CRBN mutations on response to immunomodulatory drugs and novel cereblon E3 ligase modulators in myeloma

评估 CRBN 突变对骨髓瘤免疫调节药物和新型 cereblon E3 连接酶调节剂疗效的影响

Chrisochoidou, Yakinthi; Scarpino, Andrea; Morales, Salomon; Martin, Shannon; Bird, Sarah; Li, Yigen; Walker, Brian; Caldwell, John; Le Bihan, Yann-Vaï; Pawlyn, Charlotte

Challenging the concept of functional high-risk myeloma through transcriptional and genetic profiling

通过转录组和基因谱分析挑战功能性高危骨髓瘤的概念

Beer, Sina A; Cairns, David A; Pawlyn, Charlotte; Holroyd, Amy; Ferris, Elsa; Cook, Gordon; Drayson, Mark; Boyd, Kevin; Proszek, Paula; Davies, Faith E; de Tute, Ruth; Jenner, Matthew; Morgan, Gareth J; Owen, Roger; Hubank, Michael; Houlston, Richard; Jackson, Graham; Kaiser, Martin F

Whole body MRI by MY-RADS for imaging response assessment in multiple myeloma

多发性骨髓瘤的影像学反应评估:采用 MY-RADS 进行全身 MRI 检查

Messiou, Christina; Porta, Nuria; Koh, Dow-Mu; Riddell, Angela; Downey, Katherine; Croft, James; Conneely, Leonora; Hopkinson, Georgina; Dragan, Alina; Brown, Tommy; Stern, Simon; Cheung, Betty; Kyriakou, Charalampia; Kaczmarek, Pawel; Boyd, Kevin; Pawlyn, Charlotte; Winfield, Jessica; Kaiser, Martin F

Utilizing genomics to identify novel immunotherapeutic targets in multiple myeloma high-risk subgroups

利用基因组学识别多发性骨髓瘤高危亚组中新的免疫治疗靶点

Liu, Enze; Jaouadi, Oumaima; Sharma, Riya; Becker, Nathan; Johnson, Travis S; Sudha, Parvathi; Chopra, Vivek S; Zafar, Faiza; Hamidi, Habib; Pawlyn, Charlotte; Suvannasankha, Attaya; Abonour, Rafat; Walker, Brian A

The Role of CELMoD Agents in Multiple Myeloma

CELMoD药物在多发性骨髓瘤中的作用

van de Donk, Niels W C J; Bahlis, Nizar J; Pawlyn, Charlotte; Gay, Francesca; Mateos, Maria-Victoria; Weisel, Katja; Lonial, Sagar; Richardson, Paul G

Genomic Classification and Individualized Prognosis in Multiple Myeloma

多发性骨髓瘤的基因组分类和个体化预后

Maura, Francesco; Rajanna, Arjun Raj; Ziccheddu, Bachisio; Poos, Alexandra M; Derkach, Andriy; Maclachlan, Kylee; Durante, Michael; Diamond, Benjamin; Papadimitriou, Marios; Davies, Faith; Boyle, Eileen M; Walker, Brian; Hultcrantz, Malin; Silva, Ariosto; Hampton, Oliver; Teer, Jamie K; Siegel, Erin M; Bolli, Niccolò; Jackson, Graham H; Kaiser, Martin; Pawlyn, Charlotte; Cook, Gordon; Kazandjian, Dickran; Stein, Caleb; Chesi, Marta; Bergsagel, Leif; Mai, Elias K; Goldschmidt, Hartmut; Weisel, Katja C; Fenk, Roland; Raab, Marc S; Van Rhee, Fritz; Usmani, Saad; Shain, Kenneth H; Weinhold, Niels; Morgan, Gareth; Landgren, Ola

Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry

多发性骨髓瘤患者免疫固定电泳(IFE)转阴后,其无进展生存期与质谱法检测到残留单克隆游离轻链(FLC)相关。

Giles, H V; Drayson, M T; Kishore, B; Pawlyn, C; Kaiser, M; Cook, G; de Tute, R; Owen, R G; Cairns, D; Menzies, T; Davies, F E; Morgan, G J; Pratt, G; Jackson, G H

Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm

无进展生存期作为多发性骨髓瘤临床试验的替代终点:一个不断发展的范式

Pawlyn, Charlotte; Schjesvold, Fredrik H; Cairns, David A; Wei, L J; Davies, Faith; Nadeem, Omar; Abdulhaq, Haifaa; Mateos, Maria-Victoria; Laubach, Jacob; Weisel, Katja; Ludwig, Heinz; Rajkumar, S Vincent; Sonneveld, Pieter; Jackson, Graham; Morgan, Gareth; Richardson, Paul G